ZAFIRLUKAST (Par Pharmaceutical Inc.)
Welcome to the PulseAid listing for the ZAFIRLUKAST drug offered from Par Pharmaceutical Inc.. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical Inc. |
| NON-PROPRIETARY NAME: | Zafirlukast |
| SUBSTANCE NAME: | ZAFIRLUKAST |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-12-01 |
| END MARKETING DATE: | 2018-02-28 |
ZAFIRLUKAST HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZAFIRLUKAST from Par Pharmaceutical Inc. |
| LABELER NAME: | Par Pharmaceutical Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2010-12-01 |
| END MARKETING DATE: | 2018-02-28 |
| PRODUCT ID: | 49884-304_0e2c3d04-10d8-4b5f-b702-a697d4a21076 |
| PRODUCT NDC: | 49884-304 |
| APPLICATION NUMBER: | NDA020547 |
Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers:
